Work

A phase I trial of chemoimmunotherapy combining bacillus Calmette-Guerin (BCG) and intravesical gemcitabine for patients with BCG-relapsing high-grade nonmuscle-invasive bladder cancer.

Year: 2021

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2021.39.6_suppl.tps509

Authors: Manuel R. De Jesus Escano, Daniel D. Sjoberg, Melissa McCarter, Marlena McGill, Alvin Goh, Timothy F. Donahue, S. Machele Donat, Eugene K. Cha, Harry W. Herr, Anoop M. Meraney, Hikmat A Al-Ahmadie, David B. Solit, Guido Dalbagni, Dean F. Bajorin, Bernard H. Bochner, Eugene J. Pietzak

Institutions: Memorial Sloan Kettering Cancer Center, Hartford Hospital

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3134732665

Cites:

Cited by: 1

Related to: 10